UBS Group AG - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$128
-98.5%
70
-95.6%
0.00%
Q4 2022$8,2681,587
+5190.0%
0.00%
Q3 2022$0
-100.0%
30
-99.2%
0.00%
Q2 2022$14,000
-33.3%
3,595
-9.8%
0.00%
Q4 2021$21,000
+16.7%
3,986
+32.8%
0.00%
Q3 2021$18,0000.0%3,001
+0.8%
0.00%
Q2 2021$18,000
+50.0%
2,976
+141.6%
0.00%
Q1 2021$12,0001,2320.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
DIMENSIONAL FUND ADVISORS LP 28,652$79,3660.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CITIGROUP INC 7$190.00%
MORGAN STANLEY 533$1,4760.00%
NATIONAL BANK OF CANADA /FI/ 2,255$6,2510.00%
WOLVERINE TRADING, LLC 11,700$330.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders